Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2612 of 6351
-
Which drug works best for cirrhosis patients with bleeding and kidney trouble?
Disease control Not yet recruitingAcute upper gastrointestinal bleeding (AUGIB) is a common complication in the decompensated stage of liver cirrhosis, of which approximately 70% is acute variceal bleeding (AVB) caused by portal hypertension. Existing evidence suggests that both terlipressin and somatostatin can …
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a week at sea level reset the lungs of High-Altitude dwellers?
Knowledge-focused Not yet recruitingTo study the effect of descent from high altitude (Quito Ecuador: 2850m) to sea level on six-minute walking distance and scores in healthy individuals, who live permanently \>2600m.
Sponsor: Silvia Ulrich Somaini • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Could a new HIV drug change how statins work?
Knowledge-focused Not yet recruitingResearchers are looking for new treatments for people living with HIV-1 (Human Immunodeficiency Virus Type 1). HIV-1 is the most common type of HIV, which is a virus that attacks cells of the immune system. MK-4646 is a trial medicine designed to treat HIV-1. Before giving a tri…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Blood tests may reveal hidden healing power of bone marrow stem cells
Knowledge-focused Not yet recruitingThis observational prospective cohort study will evaluate whether routine blood tests are associated with the functional quality of calcaneal bone marrow aspirate mesenchymal stem cells in adults undergoing clinically indicated foot or ankle surgery at a university hospital in Br…
Sponsor: Universidade Sao Francisco • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New cream could ease nerve pain when pills fail
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the topical anesthetic cream works to treat neuropathic chronic pain in older adults who have not found sufficient relief undergoing other pain treatments and/or medications. The safety of this drug has already been tested in other s…
Phase 1/2 • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New program aims to boost medication adherence for breast cancer patients in rwanda
Disease control Not yet recruitingThis study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda. The intervention includes educational, behavioral, and reminder components, and will be assessed for f…
Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
VR training put to the test for infection control at World's largest gathering
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to evaluate the effectiveness of immersive virtual reality (VR) training on improving infection control preparedness among healthcare workers during the Hajj pilgrimage in Saudi Arabia. The main questions this study aims to answer are: Does VR…
Sponsor: University of Bisha • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Could a tiny tube beat a single shot for foot surgery pain?
Symptom relief Not yet recruitingPostoperative pain following hindfoot surgery is often severe and can persist for several days. It frequently leads to the use of systemic analgesics, particularly opioids, whose adverse effects are well known. Furthermore, poorly controlled postoperative pain is a recognized ind…
Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can mindfulness ease trauma for Justice-Involved black teens?
Knowledge-focused Not yet recruitingThe purpose of this study is to investigate justice-involved Black/African American female adolescents' (JI BAFAs; N=35) self-reported outcomes: stress, posttraumatic stress disorder (PTSD), recidivism, etc., as well as their parents/caregivers' (P/Cs; N=35) stress and pre- and p…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis is a Phase 1, first-in-human, double-blind, placebo-controlled, adaptive-design, single-site study, involving dose exploration cohorts. During Part A, up to 4 cohorts, each consisting of approximately 14 healthy adult study participants, will be randomly allocated to receiv…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New PET scan could spot hidden kidney cancer after treatment
Diagnosis Not yet recruitingThe goal of this clinical trial is to learn whether 89Zr-Girentuximab PET scans can inform management of renal cell carcinoma. The main questions it aims to answer are: * Does the 89Zr-Girentuximab PET detect ccRCC that is left behind or has come back after treatment? * What dif…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
New hybrid rehab could help PAD patients walk farther and feel better
Symptom relief Not yet recruitingPeripheral artery disease (PAD) is a common atherosclerotic condition characterized by reduced blood flow to the lower extremities, leading to intermittent claudication, decreased walking capacity, and impaired quality of life. Supervised exercise therapy is recommended as the fi…
Sponsor: Biruni University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Daily phone Check-Ins could help veterans kick the habit
Disease control Not yet recruitingPASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use nightly surveys to optimize the intervention's effectiveness for smoking cessation among Veteran smoke…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug shows promise for rare eye muscle disease in Long-Term trial
Disease control Not yet recruitingThe purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Zapping the brain to heal after injury: new study tests tDCS for TBI
Symptom relief Not yet recruitingTraumatic Brain Injury (TBI) often results in a wide array of cognitive impairments, which can significantly diminish quality of life for affected individuals. While traditional rehabilitation methods typically adopt a standardized approach, it's crucial to acknowledge the signif…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
A simple breathing trick may calm colonoscopy nerves — a trial puts it to the test
Symptom relief Not yet recruitingThis study is a prospective, randomized controlled clinical trial designed to determine the effect of box breathing exercises on anxiety, pain, and pulmonary function in patients undergoing colonoscopy. Data will be collected using the Participant Characteristics Form, State Anxi…
Sponsor: Tarsus University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Glaucoma surgery gets a patch upgrade: which graft works best?
Disease control Not yet recruitingGlaucoma refers to a group of progressive optic neuropathies that lead to permanent vision loss. Glaucoma is the leading cause of irreversible blindness globally. In 2020, it was estimated to affect 76 million individuals worldwide, with projections indicating this number will ri…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
A drop of blood may reveal hidden fluid leaks in sepsis
Knowledge-focused Not yet recruitingThis study aims to validate a simple and reproducible index of capillary leak (CLI) in septic shock, based on haemoglobin (Hb) variation induced by standardised fluid resuscitation. To achieve this, the correlation between CLI and biomarkers of endothelial dysfunction-angiopoieti…
Sponsor: University Hospital Center of Martinique • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could arm and leg cuffs save brain cells during a stroke?
Disease control Not yet recruitingThe most common type of stroke is ischemic (lack of blood flow to the brain due to a clot blocking a blood vessel). Time is brain and an average of 1.9 million brain nerve cells per minute are destroyed in patients experiencing a typical LVO. The main goal of treatment is to help…
Phase 1/2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New Alzheimer's drug 8M2D enters first human safety trials
Disease control Not yet recruitingThis study is testing a new investigational drug called 8M2D to learn whether it is safe and well-tolerated in humans. 8M2D has not previously been given to people. Hypothesis: Researchers believe that 8M2D can be administered safely to healthy adults and to people with early Al…
Phase 1 • Sponsor: Cenna Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC